Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients.
作者信息
Mir Olivier, Dessard-Diana Bernadette, Louet Agnès Lillo-Le, Loulergue Pierre, Viard Jean-Paul, Langlois Anne, Durdux Catherine, Le Beller Christine
出版信息
Br J Clin Pharmacol. 2010 Jan;69(1):99-101. doi: 10.1111/j.1365-2125.2009.03555.x.
Abstract
摘要
相似文献
1
Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients.在HIV感染患者中，多西他赛与利托那韦之间的药代动力学相互作用导致的严重毒性。
Br J Clin Pharmacol. 2010 Jan;69(1):99-101. doi: 10.1111/j.1365-2125.2009.03555.x.
2
Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma.一名卡波西肉瘤患者中可能存在的利托那韦与多西他赛之间的药代动力学相互作用。
AIDS. 2008 Jun 19;22(10):1237-9. doi: 10.1097/QAD.0b013e328300ca98.
3
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.每日一次茚地那韦联合利托那韦：PIPO研究的初步结果。
AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032.
4
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.联合抗逆转录病毒疗法（cART）中的利托那韦成分显著改变了多西他赛的暴露量。
Cancer Chemother Pharmacol. 2014 Apr;73(4):729-36. doi: 10.1007/s00280-014-2399-7. Epub 2014 Feb 2.
5
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.利福平与沙奎那韦和低剂量利托那韦每日一次联合用药在合并结核病的HIV感染患者中的药代动力学相互作用
J Antimicrob Chemother. 2007 Apr;59(4):690-7. doi: 10.1093/jac/dkl552. Epub 2007 Feb 16.
6
Lopinavir/ritonavir: a protease inhibitor combination.
Med Lett Drugs Ther. 2001 Jan 8;43(1095):1-2.
7
[Arterial occlusion associated with interaction between ritonavir and ergotamine in HIV patient].[在一名HIV患者中，利托那韦与麦角胺相互作用导致动脉闭塞]
Farm Hosp. 2013 Sep-Oct;37(5):426-7. doi: 10.7399/FH.2013.37.5.735.
8
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma.HIV 感染霍奇金淋巴瘤患者中ritonavir 增强型蛋白酶抑制剂与长春碱的有害临床相互作用。
AIDS. 2010 Sep 24;24(15):2408-12. doi: 10.1097/QAD.0b013e32833db989.
9
Improved tolerability of ritonavir derived from pharmacokinetic principles.基于药代动力学原理提高了利托那韦的耐受性。
Br J Clin Pharmacol. 1996 Dec;42(6):787. doi: 10.1046/j.1365-2125.1996.d01-3339.x.
10
Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir doses.沙奎那韦硬胶囊/利托那韦与阿扎那韦每日一次联合给药时在接受不同阿扎那韦剂量的1型HIV感染个体中的药代动力学。
AIDS Res Hum Retroviruses. 2006 Aug;22(8):749-56. doi: 10.1089/aid.2006.22.749.
引用本文的文献
1
Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer.免疫抑制患者恶性肿瘤（包括甲状腺癌）中多激酶抑制剂的潜在应用。
Cancer Med. 2022 Oct;11 Suppl 1(Suppl 1):10-16. doi: 10.1002/cam4.5106.
2
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.重新利用的 COVID-19 药物与肺癌药物治疗的潜在药物相互作用。
Arch Med Res. 2021 Apr;52(3):261-269. doi: 10.1016/j.arcmed.2020.11.006. Epub 2020 Nov 17.
3
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors.接受多激酶抑制剂治疗的HIV感染患者中基于拉替拉韦的抗逆转录病毒疗法的安全性。
Invest New Drugs. 2017 Apr;35(2):247-249. doi: 10.1007/s10637-016-0405-0. Epub 2016 Nov 12.
4
P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug-herb/drug-drug interactions.P-糖蛋白和有机阴离子转运多肽介导的杠柳毒苷转运可能导致药物-草药/药物-药物相互作用。
Drug Des Devel Ther. 2014 May 9;8:475-83. doi: 10.2147/DDDT.S61024. eCollection 2014.
5
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.联合抗逆转录病毒疗法（cART）中的利托那韦成分显著改变了多西他赛的暴露量。
Cancer Chemother Pharmacol. 2014 Apr;73(4):729-36. doi: 10.1007/s00280-014-2399-7. Epub 2014 Feb 2.
6
Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.抗反转录病毒治疗的 HIV 感染者中的重要药物相互作用：HIV 与非 HIV 药物之间新的相互作用的更新。
Curr Infect Dis Rep. 2012 Feb;14(1):67-82. doi: 10.1007/s11908-011-0229-1.
7
Use of antineoplastic agents in patients with cancer who have HIV/AIDS.癌症合并 HIV/AIDS 患者的抗肿瘤药物应用。
Lancet Oncol. 2011 Sep;12(9):905-12. doi: 10.1016/S1470-2045(11)70056-0. Epub 2011 May 12.
本文引用的文献
1
Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma.一名卡波西肉瘤患者中可能存在的利托那韦与多西他赛之间的药代动力学相互作用。
AIDS. 2008 Jun 19;22(10):1237-9. doi: 10.1097/QAD.0b013e328300ca98.
2
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers.多西他赛联合酮康唑对晚期癌症患者进行的I期研究。
Cancer Chemother Pharmacol. 2008 Jul;62(2):243-51. doi: 10.1007/s00280-007-0598-1. Epub 2007 Oct 2.
3
Clinical pharmacodynamic factors in docetaxel toxicity.多西他赛毒性中的临床药效学因素。
Br J Cancer. 2007 Aug 6;97(3):290-6. doi: 10.1038/sj.bjc.6603872. Epub 2007 Jun 26.
4
Proposal for a new tool to evaluate drug interaction cases.关于评估药物相互作用病例的新工具的提议。
Ann Pharmacother. 2007 Apr;41(4):674-80. doi: 10.1345/aph.1H423. Epub 2007 Mar 27.
5
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study.细胞色素3A活性、炎症状态与多西他赛所致发热性中性粒细胞减少风险之间的关系：一项前瞻性研究。
Ann Oncol. 2007 Jan;18(1):168-172. doi: 10.1093/annonc/mdl321. Epub 2006 Oct 23.
6
Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.每周使用多西他赛治疗晚期获得性免疫缺陷综合征相关卡波西肉瘤是安全有效的。
Cancer. 2005 Jan 15;103(2):417-21. doi: 10.1002/cncr.20780.
7
Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma.两名艾滋病相关卡波西肉瘤患者中紫杉醇与高效抗逆转录病毒疗法之间的潜在药物相互作用。
Am J Clin Oncol. 2004 Feb;27(1):81-4. doi: 10.1097/01.coc.0000045921.91037.c8.
8
Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.利托那韦增强型蛋白酶抑制剂疗法在HIV感染患者中的药理及治疗特性
J Antimicrob Chemother. 2004 Jan;53(1):4-9. doi: 10.1093/jac/dkh029. Epub 2003 Dec 4.
9
10
Clinical pharmacokinetics of docetaxel.多西他赛的临床药代动力学
Clin Pharmacokinet. 1999 Feb;36(2):99-114. doi: 10.2165/00003088-199936020-00002.
Zotero 插件